Chronic Obstructive Pulmonary Disease and Hepatitis C
| Autor: | Dimitar T Kostadinov, Rosen E Petkov, Deian T Jelev, Krasimir A Antonov, Evgeni V Mekov |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Hepatitis C virus Pulmonary disease lcsh:Medicine Disease medicine.disease_cause Risk Assessment Severity of Illness Index Gastroenterology Pulmonary Disease Chronic Obstructive 03 medical and health sciences Age Distribution 0302 clinical medicine Internal medicine Prevalence medicine Humans COPD Sex Distribution Risk factor Lung function business.industry lcsh:R virus diseases General Medicine Hepatitis C Hepatitis C Chronic Prognosis medicine.disease Comorbidity digestive system diseases respiratory tract diseases comorbidity 030228 respiratory system HCV Disease Progression Female 030211 gastroenterology & hepatology hepatitis C business |
| Zdroj: | Folia Medica, Vol 59, Iss 2, Pp 132-138 (2017) |
| ISSN: | 1314-2143 |
| Popis: | Chronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations. COPD patients have increased prevalence of HCV and patients with HCV, especially older ones, have increased prevalence and faster progression of COPD. HCV infection exerts long-term effects on lung tissue and is an additional risk factor for the development of COPD. The presence of HCV is associated with an accelerated loss of lung function in COPD patients, especially in current smokers. COPD could represent extrahepatic manifestation associated with HCV infection. The aim of this article was to review the literature on prevalence of HCV in COPD and vice versa, pathogenetic link and the consequences of their mutual existence. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|